Fiduciary Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,414
Closed -$207K 628
2022
Q4
$207K Sell
7,414
-1,622
-18% -$41.5K ﹤0.01% 596
2022
Q3
$212K Sell
9,036
-1,199
-12% -$36.2K ﹤0.01% 580
2022
Q2
$345K Sell
10,235
-1,964
-16% -$68.8K 0.01% 516
2022
Q1
$426K Sell
12,199
-1,427
-10% -$48.8K 0.01% 501
2021
Q4
$415K Sell
13,626
-9,910
-42% -$323K 0.01% 501
2021
Q3
$772K Sell
23,536
-14,568
-38% -$466K 0.01% 383
2021
Q2
$1.15M Buy
+38,104
New +$1.25M 0.02% 316

Other funds holding OGN

Fiduciary Trust's OGN Position: Q1 2023 in Review

Fiduciary Trust sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 7,414 shares — an estimated $207K sold.

Fiduciary Trust first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $1.15M in Q2 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Fiduciary Trust reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Fiduciary Trust sold 7,414 Organon & Co shares in Q1 2023, an estimated $207K.
  • Fiduciary Trust first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Fiduciary Trust's Organon & Co position peaked at $1.15M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Fiduciary Trust's 13F filing for Q1 2023, filed 15 May 2023.